a Cochrane South Africa, South African Medical Research Council , Cape Town , South Africa.
b Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics , Department of Global Health, Stellenbosch University , Cape Town , South Africa.
Hum Vaccin Immunother. 2018;14(10):2447-2451. doi: 10.1080/21645515.2018.1475815. Epub 2018 Jun 21.
We describe the existence and functionality of National Immunisation Technical Advisory Groups (NITAGs) in Africa between 2010 and 2016, using data from the WHO-UNICEF Joint Reporting Form. The number of African countries with NITAGs increased from 15 (28%) in 2010 to 26 (48%) in 2016. Countries with a functioning NITAG increased from 5(9%) in 2010 to 16 (30%) in 2016. In 2016, 13 of the 27 (48%) low-income African countries reported having a NITAG; seven (54%) of them functional. Thirteen of the 26 (50%) middle-income countries reported having a NITAG; nine (69%) of them functional. In 2016, six of the seven African countries (86%) in the WHO Eastern Mediterranean Region had a NITAG, with three (50%) functional. In the WHO African Region, 20 of the 47 countries (43%) had NITAGs; 13 (65%) of them functional. Substantial investments should be made to ensure that every African country has a functional NITAG.
我们描述了 2010 年至 2016 年间非洲国家免疫技术咨询小组(NITAG)的存在和功能,数据来自世卫组织-儿基会联合报告表。有 NITAG 的非洲国家数量从 2010 年的 15 个(28%)增加到 2016 年的 26 个(48%)。有运作中的 NITAG 的国家从 2010 年的 5 个(9%)增加到 2016 年的 16 个(30%)。2016 年,27 个低收入非洲国家中有 13 个(48%)报告称有 NITAG;其中 7 个(54%)运作正常。26 个中等收入国家中有 13 个(50%)报告称有 NITAG;其中 9 个(69%)运作正常。在世卫组织东地中海区域的 7 个非洲国家中,有 6 个(86%)在 2016 年有 NITAG,其中 3 个(50%)运作正常。在非洲区域,47 个国家中有 20 个(43%)有 NITAG;其中 13 个(65%)运作正常。应该进行大量投资,以确保每个非洲国家都有一个运作正常的 NITAG。